DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,109 filers reported holding DANAHER CORPORATION in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86,091 | +15.3% | 347 | +11.6% | 0.04% | +16.7% |
| Q2 2023 | $74,640 | +13.9% | 311 | +19.6% | 0.04% | +2.9% |
| Q1 2023 | $65,530 | -91.3% | 260 | -90.8% | 0.04% | -87.8% |
| Q4 2022 | $752,200 | +4.5% | 2,834 | +1.7% | 0.29% | -2.0% |
| Q3 2022 | $719,854 | +2.4% | 2,787 | +0.5% | 0.29% | +5.0% |
| Q2 2022 | $703,011 | -13.9% | 2,773 | -0.4% | 0.28% | -0.7% |
| Q1 2022 | $816,924 | -10.5% | 2,785 | +0.4% | 0.28% | -7.6% |
| Q4 2021 | $912,345 | +8.3% | 2,773 | +0.3% | 0.30% | -2.3% |
| Q3 2021 | $842,081 | +13.6% | 2,766 | +0.1% | 0.31% | +14.8% |
| Q2 2021 | $741,210 | +19.2% | 2,762 | 0.0% | 0.27% | +10.6% |
| Q1 2021 | $621,671 | +1.3% | 2,762 | 0.0% | 0.24% | -5.8% |
| Q4 2020 | $613,551 | +3.7% | 2,762 | +0.5% | 0.26% | -9.1% |
| Q3 2020 | $591,942 | +21.9% | 2,749 | +0.1% | 0.29% | +12.6% |
| Q2 2020 | $485,398 | +28.1% | 2,745 | +0.3% | 0.25% | +6.7% |
| Q1 2020 | $378,828 | -9.6% | 2,737 | +0.3% | 0.24% | +10.7% |
| Q4 2019 | $418,847 | +3.6% | 2,729 | -2.5% | 0.22% | -4.9% |
| Q3 2019 | $404,115 | +1.1% | 2,798 | 0.0% | 0.23% | -1.7% |
| Q2 2019 | $399,890 | +9.1% | 2,798 | +0.8% | 0.23% | +7.5% |
| Q1 2019 | $366,620 | +28.7% | 2,777 | +0.5% | 0.21% | +16.3% |
| Q4 2018 | $284,817 | -5.1% | 2,762 | 0.0% | 0.18% | -6.6% |
| Q3 2018 | $300,119 | +10.1% | 2,762 | 0.0% | 0.20% | +3.7% |
| Q2 2018 | $272,554 | +0.8% | 2,762 | 0.0% | 0.19% | -2.1% |
| Q1 2018 | $270,427 | +5.5% | 2,762 | 0.0% | 0.19% | +3.2% |
| Q4 2017 | $256,369 | +8.2% | 2,762 | 0.0% | 0.19% | +3.9% |
| Q3 2017 | $236,924 | +0.2% | 2,762 | -1.4% | 0.18% | -3.2% |
| Q2 2017 | $236,461 | -0.4% | 2,802 | +0.9% | 0.19% | -6.0% |
| Q1 2017 | $237,431 | +9.9% | 2,776 | 0.0% | 0.20% | +3.1% |
| Q4 2016 | $216,084 | +0.8% | 2,776 | +1.5% | 0.19% | -1.5% |
| Q3 2016 | $214,475 | -22.4% | 2,736 | 0.0% | 0.20% | -24.9% |
| Q2 2016 | $276,336 | +6.5% | 2,736 | 0.0% | 0.26% | +6.1% |
| Q1 2016 | $259,537 | – | 2,736 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |